Olimel N7E inf. emuls. i.v.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Achète-le

Ingrédients actifs:

Sodium Acetate Trihydrate 1,5 g/l; Sodium Glycerophosphate Hydrate - Eq. Sodium Glycerophosphate 3,67 mg/ml; Glycine 3,07 mg/ml; Glutamic Acid 2,21 mg/ml; Valine 2,83 mg/ml; Arginine 4,34 mg/ml; Leucine 3,07 mg/ml; Potassium Chloride 2,24 mg/ml; Magnesium Chloride Hexahydrate 0,81 mg/ml; Serine 1,75 mg/ml; Proline 2,64 mg/ml; Alanine 6,41 mg/ml; Lysine Acetate 4,88 g/l - Eq. Lysine 3,48 mg/ml; Histidine 2,64 mg/ml; Threonine 2,21 mg/ml; Tryptophan 0,74 mg/ml; Soyabean Oil + Olive Oil 40 mg/ml; Aspartic Acid 1,28 mg/ml; Glucose Monohydrate 154 mg/ml - Eq. Glucose Anhydrous 140 g/l; Calcium Chloride Dihydrate 0,52 g/l; Tyrosine 0,11 mg/ml; Isoleucine 2,21 mg/ml; Methionine 2,21 mg/ml; Phenylalanine 3,07 mg/ml

Disponible depuis:

Baxter SA-NV

Code ATC:

B05BA10

DCI (Dénomination commune internationale):

Histidine; Valine; Methionine; Lysine Acetate; Magnesium Chloride Hexahydrate; Glucose Monohydrate; Tryptophan; Glutamic Acid; Aspartic Acid; Arginine; Glycine; Tyrosine; Threonine; Leucine; Proline; Sodium Glycerophosphate Hydrate; Soyabean Oil + Olive Oil; Potassium Chloride; Isoleucine; Sodium Acetate Trihydrate; Phenylalanine; Alanine; Serine; Calcium Chloride Dihydrate

forme pharmaceutique:

Emulsion for infusion

Composition:

Histidine 2.64 mg/ml; Valine 2.83 mg/ml; Methionine 2.21 mg/ml; Lysine Acetate; Magnesium Chloride Hexahydrate 0.81 mg/ml; Glucose Monohydrate 154 mg/ml; Tryptophan 0.74 mg/ml; Glutamic Acid 2.21 mg/ml; Aspartic Acid 1.28 mg/ml; Arginine 4.34 mg/ml; Glycine 3.07 mg/ml; Tyrosine 0.11 mg/ml; Threonine 2.21 mg/ml; Leucine 3.07 mg/ml; Proline 2.64 mg/ml; Sodium Glycerophosphate Hydrate; Soyabean Oil + Olive Oil 40 mg/ml; Potassium Chloride 2.24 mg/ml; Isoleucine 2.21 mg/ml; Sodium Acetate Trihydrate; Phenylalanine 3.07 mg/ml; Alanine 6.41 mg/ml; Serine 1.75 mg/ml; Calcium Chloride Dihydrate

Mode d'administration:

Intravenous use

Domaine thérapeutique:

Combinations

Descriptif du produit:

CTI code: 370903-01 - Pack size: 4 x 2000 ml - Commercialisation status: YES - CNK code: 2786135 - Delivery mode: Medical prescription; CTI code: 370885-01 - Pack size: 6 x 1000 ml - Commercialisation status: YES - CNK code: 2786119 - Delivery mode: Medical prescription; CTI code: 370894-01 - Pack size: 4 x 1500 ml - Commercialisation status: YES - CNK code: 2786127 - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: Yes

Date de l'autorisation:

2010-06-04

Documents dans d'autres langues

Notice patient Notice patient allemand 01-07-2022
Notice patient Notice patient français 01-07-2022
DHPC DHPC français 25-10-2022
Notice patient Notice patient néerlandais 01-07-2022
DHPC DHPC néerlandais 25-10-2022

Afficher l'historique des documents